Most Bio's were smart enough to raise cash during the recent Bio market run. Sometimes I wonder if these sector spurts are just set up to pull punters in for CR's. Anyway the Biotech lesson learned over and over again is to always take profits in the SP run up to trial results. PBT PRR PXS CBZ and countless overs proves to exit before results. IMHO
